PDL BioPharma Inc (NASDAQ:PDLI)

6.41
Delayed Data
As of Jul 01
 0.00 / 0.00%
Today’s Change
6.18
Today|||52-Week Range
10.26
-16.86%
Year-to-Date

Today’s Trading

Previous close6.41
Today’s openn.a.
Day’s range-- - --
Volume25,741
Average volume (3 months)3,012,888
Market cap$1.1B
Dividend yield9.36%
Data as of 07/01/2015

Growth & Valuation

Earnings growth (last year)+12.05%
Earnings growth (this year)+13.17%
Earnings growth (next 5 years)+17.00%
Revenue growth (last year)+31.23%
P/E ratio3.4
Price/Sales2.30
Price/Book2.26

Competitors

 Today’s
change
Today’s
% change
ACHNAchillion Pharmaceut...0.000.00%
ARRYArray Biopharma Inc0.000.00%
HRTXHeron Therapeutics I...0.000.00%
ITCIIntra-Cellular Thera...0.000.00%
Data as of 07/01/2015

Financials

Next reporting dateJuly 29, 2015
EPS forecast (this quarter)$0.52
Annual revenue (last year)$581.2M
Annual profit (last year)$322.2M
Net profit margin55.44%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John Peter McLaughlin
Chief Financial Officer &
Vice President
Peter S. Garcia
Corporate headquarters
Incline Village, Nevada

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers